Efficacy and safety of incretin co agonists: Transformative advances in cardiometabolic healthcare Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial The Lancet Efficacy and Safety of Tirzepatide for Weight Management in Non Diabetic Obese Individuals: A Narrative Review For an adult with type 2 diabetes mellitus who requires substantial weight loss, what are the recommended use, dosing, regulatory approval status, and contraindications of tirzepatide compared with cagrilintide, and what alternative Cagrilintide: The Next Gen Peptide for Weight Loss and Satiety Hubmed